VitaSpring Biomedical Co. Ltd. (VSBC) stock
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
VitaSpring Biomedical's price to sales ratio was 470.9× on Jun 30, 2022, against 463.9× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jun 30, 2022 | 470.9× | +459.9 |
| 2021 | Feb 26, 2021 | 11.0× | +0.0 |
| 2020 | Dec 31, 2020 | 11.0× | −452.9 |
| 2019 | Dec 31, 2019 | 463.9× | – |
See a number that looks wrong?